(NP (NP (NP (JJ Novel) (NN aldosterone) (NNS receptors)) (: :) (NP (NP (JJ specificity-conferring) (NN mechanism)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (NN cell) (NN membrane))))) (. .))))
(S (NP-SBJ (NP (JJ Functional) (NNS studies)) (PP (IN in) (NP (NP (ADJP-COOD (ADJP (JJ extra-renal)) (, ,) (ADJP (JJ nonepithelial))) (NNS cells)) (PP (JJ such) (IN as) (NP-COOD (NP (JJ smooth) (NN muscle) (NNS cells)) (CC and) (NP (ADVP-TMP (RBR more) (RB recently)) (NP (VBG circulating) (JJ human) (NNS lymphocytes)))))))) (VP (VBP have) (VP (VBN provided) (NP (VBG increasing) (NN evidence) (SBAR (IN that) (S (NP-SBJ (NN aldosterone)) (VP (VBZ produces) (NP (NP-COOD (CONJP (RB not) (RB only)) (NP (JJ classical) (JJ genomic) (NNS effects)) (, ,) (CONJP (CC but) (RB also)) (NP (JJ rapid) (JJ non-genomic) (NNS effects))) (PP (IN on) (NP (NN transmembrane) (NN electrolyte) (NNS movements)))))))))) (. .))
(S (NP-SBJ (DT These)) (VP (VBP involve) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NN (proton-exchanger sodium))) (PP (IN of) (NP (DT the) (NN cell) (NN membrane))))) (PP (IN at) (NP (NP (ADJP-COOD (ADJP (RB very) (JJ low)) (, ,) (ADJP (JJ physiological))) (NNS concentrations)) (PP (IN of) (NP (NN aldosterone))))) (PP (IN with) (NP (NP (DT an) (JJ acute) (NN onset)) (PP-TMP (IN within) (NP (QP (CD 1-2)) (NNS minutes))))))) (. .))
(S (NP-SBJ (NP (DT A) (JJ second) (NN messenger) (NN cascade)) (VP (VBN involved) (NP (-NONE- *)))) (VP (VBZ is) (NP-PRD (NP (DT the) (NN (calcium inositol-1,4,5-trisphosphate)) (NN pathway)) (SBAR (WHNP-5 (WDT which)) (S (NP-SBJ (-NONE- *T*-5)) (VP (VBZ responds) (PP-TMP (IN over) (NP (DT the) (JJ same) (JJ rapid) (NN time) (NN course)))))))) (. .))
(S (NP-SBJ-6 (JJ Such) (NNS changes)) (ADVP (RB clearly)) (VP (MD can) (RB not) (VP (VB be) (VP (VBN explained) (NP (-NONE- *-6)) (PP (IN by) (NP-LGS (NP (JJ genomic) (NNS mechanisms)) (, ,) (SBAR (WHNP-7 (WDT which)) (S (NP-SBJ (-NONE- *T*-7)) (VP (VBP are) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (JJ later) (NNS effects)) (PP (IN than) (NP (DT the) (JJ membrane-related) (JJ rapid) (NNS responses)))))))))))))) (. .))
(S (PP (IN In) (NN addition) (TO to) (NP (PRP$ its) (JJ rapid) (NN time) (NN course))) (NP-SBJ (NP (DT the) (JJ unique) (NNS characteristics)) (PP (IN of) (NP (NP (DT this) (JJ new) (NN pathway)) (PP (IN for) (NP (NN steroid) (NN action)))))) (VP (VBP include) (NP-COOD (NP (NP (DT a) (JJ 10000-fold) (NN selectivity)) (PP (IN for) (NP (NN aldosterone))) (PP (IN over) (NP (NN cortisol)))) (CC and) (NP (NP (DT the) (NN ineffectiveness)) (PP (IN of) (NP (NP (NNS spironolactones)) (, ,) (NP (JJ classical) (NN mineralocorticoid) (NNS antagonists)) (, ,))) (PP (IN as) (NP (NP (NNS antagonists)) (PP (IN of) (NP (DT the) (NN response)))))))) (. .))
(S (NP-SBJ-8 (NP (ADJP (RB Subsequently) (VBG binding)) (NNS sites)) (SBAR (-NONE- *ICH*-9))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (NP (-NONE- *-8)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NN membrane)) (PP (IN of) (NP (JJ human) (NNS lymphocytes))))) (SBAR-9 (WHNP-10 (WDT which)) (S (NP-SBJ (-NONE- *T*-10)) (VP (VBP show) (NP (NP (NP-COOD (NP (NP (JJ pharmacological) (NP (-NONE- *RNR*-11))) (PRN (-LRB- -LRB-) (NP (NN aldosterone) (NN specificity)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ kinetic) (NP (-NONE- *RNR*-11))) (PRN (-LRB- -LRB-) (NP (JJ high) (NN turnover)) (-RRB- -RRB-)))) (NP-11 (NNS properties))) (ADJP (JJ identical) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT the) (JJ rapid) (NN aldosterone) (NNS effects)) (PP (IN in) (NP (DT the) (JJ same) (NNS cells))))))))))))))) (. .))
(S (NP-SBJ (NP (NN SDS-PAGE) (NN analysis)) (PP (IN of) (NP (DT the) (NN receptor) (NN protein)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT a) (JJ molecular) (NN weight)) (PP (IN of) (NP (QP (RB approximately) (CD 50)) (NN kD)))))) (. .))
(S (NP-SBJ (DT The) (JJ present) (NN paper)) (VP (VBZ reviews) (NP (NP (DT the) (NNS data)) (VP (VBG supporting) (NP (NP (DT a) (ADJP-COOD (ADJP (JJ new)) (, ,) (ADJP (JJ two-step))) (NN model)) (PP (IN for) (NP (ADJP-COOD (ADJP (JJ non-genomic)) (CC and) (ADJP (JJ genomic))) (NN aldosterone) (NNS effects))))))) (. .))
(S (NP-SBJ (PRP It)) (ADVP (RB also)) (VP (VBZ suggests) (NP (NP (DT a) (JJ novel) (JJ specificity-conferring) (NN mechanism)) (PP (IN for) (NP (NP (NN mineralocorticoid) (NN action)) (PP (IN at) (NP (DT the) (NN membrane) (NN level))))))) (. .))
